Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450411 · ClinicalTrials.gov registry record · Phase 2
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00450411 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 100 participants.
The verdict
NCT00450411, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
RATIONALE: Implant radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. PURPOSE: This phase II trial is studying the side effects and how well ultrasound-guided implant radiation therapy works in treating patients with locally recurrent prostate cancer previously treated with external-beam radiation therapy.
Interventions
- RADIATION 125-Iodine
- RADIATION 103-palladium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2007-05 |
| Est. Completion | 2022-05-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00450411
The ClinicalTrials.gov registry entry for NCT00450411 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 125-Iodine is the first listed.
NCT00450411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00450411 about?
NCT00450411 is a clinical study titled "Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy". RATIONALE: Implant radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. PURPOSE: This phase II trial is studying the side effects and how well ultrasound-guided implant radiation therapy works in treating patients with locally recurrent prostate canc...
What is the current status of trial NCT00450411?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2007-05. Estimated completion is 2022-05-20.
What interventions are being tested in trial NCT00450411?
The interventions under investigation include: 125-Iodine (RADIATION), 103-palladium (RADIATION).
Who is sponsoring clinical trial NCT00450411?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.